학술논문

Biomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC).
Document Type
Article
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p608-608, 1p
Subject
Language
ISSN
0732183X